Decoy Biosystems

About:

Decoy Biosystems is a biotechnology company developing novel, multi-targeted products designed to eliminate viral and bacterial infections.

Website: https://www.decoybio.com

Top Investors: Mountain Pacific Partners, TY BIO Investment

Description:

Decoy Biosystems is a biotechnology company developing a novel and potentially best in class, multiple Toll-like receptor (TLR) agonist-based cancer immunotherapy. Decoy is dedicated to enhancing the expanding curative cancer immunology for patients with unresectable or metastatic solid tumors and lymphomas, which are responsible for approximately 90 percent of all cancer deaths.

Total Funding Amount:

$6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-08-14

Founders:

Michael Newman

Number of Employees:

11-50

Last Funding Date:

2018-10-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai